Hyperglycemia increases the complicated infection and mortality rates during induction therapy in adult acute leukemia patients

Revista Brasileira de Hematologia e Hemoterapia

Volumn 35, Issue 1, 2013, Pages 39-43

  do Nascimento Matias, Carolina ^a   Lima, Vladmir ^b   Teixeira, Heberton Medeiros ^a   Souto, Fernanda Ribeiro ^c   Magalhães, Vera ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

^c Hospital de Hematologia e Hemoterapia de Pernambuco HEMOPE   (Brazil)

Author keywords

Fever; Hyperglycemia; Infection; Leukemia; Mortality; Neutropenia

Indexed keywords

EID: 84876055844     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.5581/1516-8484.20130013     Document Type: Article

References (25)

1. Baker EH, Janaway CH, Philips BJ, Brennan AL, Baines DL, Wood DM, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006;61(4):284-289. Comment in: Thorax. 2006;61(4):275-6.
2. Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia. 2007;50(3):549-554.
3. Fahy BG, Sheehy AM, Coursin DB. Glucose control in the intensive care unit. Crit Care Med. 2009;37(5):1769-1776.
4. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978-982. Comment in: J Clin Endocrinol Metab. 2003;88(3):1402; author reply 1402; J Clin Endocrinol Metab. 2002;87(3):975-7.
5. Kavanagh BP, McCowen KC. Clinical practice. Glycemic control in the ICU. N Engl J Med. 2010;363(26):2540-2546. Erratum in: N Engl J Med. 2011;364(12):1182; Comment in: N Engl J Med. 2011;364(13):1280; author reply 1281.
6. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359-1367. Comment in: Curr Surg. 2005;62(3):277-82; Curr Gastroenterol Rep. 2011;13(4):301-5; Evid Based Nurs. 2002;5(2):53; ACP J Club. 2002;136(6):81; N Engl J Med. 2002;346(20):1586-8; author reply 1586-8; Nutr Clin Pract. 2004;19(2):181-3; N Engl J Med. 2001;34519):1417-8; N Engl J Med. 2006; 354(19):2069-71; author reply 2069-71.
7. Subramaniam B, Panzica PJ, Novack V, Mahmood F, Matyal R, Mitchell JD, et al. Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology; 2009;110(5):970-977. Comment in: Anesthesiology. 2009;110(5):957-8.
8. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su S Y, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ.Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-1297. Comment in: Curr Hypertens Rep. 2009;11(6):383-4; Can J Anaesth. 2010;57(2):172-5; Curr Infect Dis Rep. 2009;11(5):335-6; Internist (Berl). 2010;51(5):670, 672-3; N Engl J Med. 2009;360(13):1346-9;N Engl J Med. 2009;361(1):90-1; author reply 91-2; J Fam Pract. 2009;58(8):424-6; Ann Intern Med. 2009;151(4):JC2-5; N Engl J Med. 2009;361(1):89-90; author reply 91-2.
9. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med. 1997;14(1):29-34.
10. Sakowicz-Burkiewicz M, Kocbuch K, Grden M, Szutowicz A, Pawelczyk T. Diabetes- induced decrease of adenosine kinase expression impairs the proliferation potential of diabetic rat T lymphocytes. Immunology. 2006;118(3):402-412.
11. Hostetter MK. Handicaps to host defense: effects of hyperglycemia on C3 and candida albicans. Diabetes. 1990;39(3):271-275.
12. Black CT, Hennessey PJ, Andrassy RJ. Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulin. J Trauma. 1990;30(7):830-832; discussion 832-3.
13. Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low risk febrile neutropenic cancer patients. J Clin Oncol. 2000;18(16):3038-3051.
14. Ali NA, O'Brien JM Jr, Blum W, Byrd JC, Klisovic RB, Marcucci G, et al. Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality. Cancer. 2007;110(1):96-102.
15. Howard SC, Pui CH. Endocrine complications in pediatric patients with acute lymphoblastic leukemia. Blood Rev. 2002;16(4):225-243.
16. Pui CH, Burghen GA, Bowman WP, Aur RJ. Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisone. J Pediatr. 1981;99(1):46-50.
17. Roberson JR, Spraker HL, Shelso J, Zhou Y, Inaba H, Metzger ML, et al. Clinical consequences of hyperglycemia during remission induction therapy for pediatric acute lymphocytic leukemia. Leukemia. 2009;23(2):245-250.
18. Sonabend RY, McKay SV, Okcu MF, Yan J, Haymond MW, Margolin JF. Hyperglycemia during induction therapy is associated with increased infectious complications in childhood acute lymphocytic leukemia. Pediatr Blood Cancer. 2008;51(3):387-392.
19. Weiser MA, Cabanillas ME, Konopleva M, Thomas DA, Pierce SA, Escalante CP, et al. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone/methotrexate cytarabine regimen. Cancer. 2004;100(6):1179-1185. Comment: Cancer. 2004;101(5):1100-1; author reply 1101.
20. American Diabetes Association. Standards of medical care in diabetes--2010. Diabetes Care. 2010;33(Suppl 1):S11-S61. Erratum in: Diabetes Care. 2010;33(3):692.
21. Derr RL, Hsiao VC, Saudek CD. Antecedent hyperglycemia is associated with an increased risk of neutropenic infections during bone marrow transplantation. Diabetes Care. 2008;31(10):1972-1977.
22. Fuji S, Kim SW, Mori S, Fukuda T, Kamiya S, Yamasaki S, et al. Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation. Transplantation. 2007; 84(7):814-820.
23. Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36(12):3190-3197. Comment in: Crit Care Med. 2008;36(12):3271-2.
24. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffer M, Reinhart K; German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125-139. Comment in: Am J Kidney Dis. 2008;52(1):13-7; ACP J Club. 2008;148(4):4; N Engl J Med. 2008;358(19):2072; author reply 2074-5; Can J Surg. 2009;52(6):512-4; N Engl J Med. 2008;358(19):2073; author reply 2074-5; N Engl J Med. 2008;358(19):2073; author reply 2074-5; Anaesthesist. 2008;57(7):723-8; CJEM. 2010;12(1):58-61. N Engl J Med. 2008;358(19):2072-3; author reply 2074-5.
25. Preiser JC, Devos P, Ruiz-Santana S, Mélot C, Annane D, Groeneveld J, et al. A prospective randomized multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35(10):1738-1748. Comment in: Intensive Care Med. 2010; 36(1):173-4; author reply 175-6.